Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
Courtney D. DiNardo(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Elie Traer(Memorial Sloan Kettering Cancer Center), Stephanie M. Kapsalis(Memorial Sloan Kettering Cancer Center), Amir T. Fathi(University of Southern California), Hua Yang(China Pharmaceutical University), Gail J. Roboz(Cornell University), Martha Arellano(Memorial Sloan Kettering Cancer Center), Robert K. Stuart(Memorial Sloan Kettering Cancer Center), Hua Liu(Memorial Sloan Kettering Cancer Center), Stéphane de Botton(Université Paris-Saclay), Anthony S. Stein(University of Hohenheim), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jessica K. Altman(Northwestern University), Christophe Willekens(Université Paris-Saclay), Daniel A. Pollyea(University of Colorado Denver), Ronan Swords(University of Miami), James M. Foran(Memorial Sloan Kettering Cancer Center), Bin Fan(Memorial Sloan Kettering Cancer Center), Meredith A. Goldwasser(Memorial Sloan Kettering Cancer Center), Will Donnellan(Memorial Sloan Kettering Cancer Center), Sung Choe(Agios Pharmaceuticals (United States)), Harry P. Erba(Michigan Center for Translational Pathology), Katharine Yen(Agios Pharmaceuticals (United States)), Mikkael A. Sekeres(University of Miami), David L. Dai(Memorial Sloan Kettering Cancer Center), Sam Agresta(Agios Pharmaceuticals (United States)), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Gabrielle T. Prince(Johns Hopkins University), Richard M. Stone(Dana-Farber Cancer Institute), Gabriel N. Mannis(Stanford University), Robert H. Collins(Texas Oncology), Eyal C. Attar(Memorial Sloan Kettering Cancer Center), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Bin Wu(Memorial Sloan Kettering Cancer Center), Hongfang Wang(Memorial Sloan Kettering Cancer Center), Vickie Zhang(Memorial Sloan Kettering Cancer Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), James L. Slack(Memorial Sloan Kettering Cancer Center), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux)
Cited by 1,408
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k